Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 1
1971 3
1972 3
1973 1
1975 1
1976 1
1977 1
1978 1
1979 1
1980 4
1981 2
1982 3
1983 5
1984 7
1985 5
1986 8
1987 8
1988 11
1989 6
1990 14
1991 16
1992 7
1993 16
1994 24
1995 41
1996 35
1997 38
1998 35
1999 49
2000 54
2001 43
2002 47
2003 49
2004 61
2005 62
2006 64
2007 46
2008 55
2009 51
2010 39
2011 41
2012 39
2013 43
2014 43
2015 44
2016 41
2017 35
2018 33
2019 26
2020 19
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,174 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Côté I, Parent J, Lavoie L, BSc AB, Martel C, Vaillancourt M, Balser J, Moyneur É; members of the VVA Prasterone Research Group. Labrie F, et al. Menopause. 2018 Nov;25(11):1339-1353. doi: 10.1097/GME.0000000000001238. Menopause. 2018. PMID: 30358731 Clinical Trial.
OBJECTIVE: The aim of this study is to confirm the local beneficial effects of intravaginal dehydroepiandrosterone (DHEA, Prasterone) on moderate to severe dyspareunia or pain at sexual activity, the most frequent symptom of vulvovaginal atrophy due to menopause or …
OBJECTIVE: The aim of this study is to confirm the local beneficial effects of intravaginal dehydroepiandrosterone (DHEA, Prastero
Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause.
Labrie F, Archer DF, Martel C, Vaillancourt M, Montesino M. Labrie F, et al. Menopause. 2017 Nov;24(11):1246-1256. doi: 10.1097/GME.0000000000000910. Menopause. 2017. PMID: 28640161 Clinical Trial.
OBJECTIVE: To analyze the effects of intravaginal prasterone obtained in the three randomized clinical studies performed in postmenopausal women suffering from moderate to severe (MS) dyspareunia due to vulvovaginal atrophy (VVA). ...RESULTS: In 436 women treated with 0.50 …
OBJECTIVE: To analyze the effects of intravaginal prasterone obtained in the three randomized clinical studies performed in postmenop …
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.
Wu G, Hu X, Ding J, Yang J. Wu G, et al. J Ovarian Res. 2020 May 9;13(1):57. doi: 10.1186/s13048-020-00650-7. J Ovarian Res. 2020. PMID: 32386521 Free PMC article. Clinical Trial.
All the PCOS rats were administrated with 6 mg/100 g dehydroepiandrosterone (DHEA) for 20 consecutive days, all the PCOS+Gln groups were intraperitoneal injected glutamine twice in the next morning after the last DHEA injection. ...
All the PCOS rats were administrated with 6 mg/100 g dehydroepiandrosterone (DHEA) for 20 consecutive days, all the PCOS+Gln groups w …
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE. Petri MA, et al. Arthritis Rheum. 2004 Sep;50(9):2858-68. doi: 10.1002/art.20427. Arthritis Rheum. 2004. PMID: 15452837 Free article. Clinical Trial.
OBJECTIVE: To determine whether prasterone administration results in improvement or stabilization of systemic lupus erythematosus (SLE) disease activity and its symptoms. ...Acne and hirsutism were reported in 33% and 16%, respectively, of the prasterone group and i …
OBJECTIVE: To determine whether prasterone administration results in improvement or stabilization of systemic lupus erythematosus (SL …
The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E. von Mühlen D, et al. Contemp Clin Trials. 2007 Feb;28(2):153-68. doi: 10.1016/j.cct.2006.04.009. Epub 2006 May 6. Contemp Clin Trials. 2007. PMID: 16784898 Clinical Trial.
Levels of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS), the major secretory products of the adrenal gland, decline dramatically with age, concurrent with the onset of degenerative changes and chronic diseases associated with aging. ...
Levels of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS), the major secretory products of the adrenal gland, decline dramatic …
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J. Labrie F, et al. Menopause. 2009 Sep-Oct;16(5):907-22. doi: 10.1097/gme.0b013e31819e8e2d. Menopause. 2009. PMID: 19436225 Clinical Trial.
OBJECTIVE: Because the secretion of dehydroepiandrosterone (DHEA), the exclusive source of sex steroids in postmenopausal women, is already decreased by 60% and continues to decline at the time of menopause, the objective of this study was to examine the effect of intravag …
OBJECTIVE: Because the secretion of dehydroepiandrosterone (DHEA), the exclusive source of sex steroids in postmenopausal women, is a …
Associations of IGF-1 and Adrenal Androgens with Cognition in Childhood.
Mäntyselkä A, Haapala EA, Lindi V, Häkkinen MR, Auriola S, Jääskeläinen J, Lakka TA. Mäntyselkä A, et al. Horm Res Paediatr. 2019;91(5):329-335. doi: 10.1159/000501719. Epub 2019 Aug 9. Horm Res Paediatr. 2019. PMID: 31401625 Clinical Trial.
BACKGROUND: Little is known about the association between adrenarche and cognition in general populations of children. We therefore studied the associations of dehydroepiandrosterone sulfate (DHEAS), androstenedione (A4), testosterone, insulin-like growth factor-1 (IGF-1), …
BACKGROUND: Little is known about the association between adrenarche and cognition in general populations of children. We therefore studied …
Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial.
Ritsner MS, Gibel A, Shleifer T, Boguslavsky I, Zayed A, Maayan R, Weizman A, Lerner V. Ritsner MS, et al. J Clin Psychiatry. 2010 Oct;71(10):1351-62. doi: 10.4088/JCP.09m05031yel. Epub 2010 Jun 15. J Clin Psychiatry. 2010. PMID: 20584515 Clinical Trial.
OBJECTIVE: Pregnenolone (PREG) and dehydroepiandrosterone (DHEA) are reported to have a modulatory effect on neuronal excitability, synaptic plasticity, and response to stress; they are associated with mood regulation and cognitive performance. ...
OBJECTIVE: Pregnenolone (PREG) and dehydroepiandrosterone (DHEA) are reported to have a modulatory effect on neuronal excitability, s …
Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone).
Archer DF, Labrie F, Bouchard C, Portman DJ, Koltun W, Cusan L, Labrie C, Côté I, Lavoie L, Martel C, Balser J; VVA Prasterone Group. Archer DF, et al. Menopause. 2015 Sep;22(9):950-63. doi: 10.1097/GME.0000000000000428. Menopause. 2015. PMID: 25734980 Clinical Trial.
OBJECTIVE: This study aims to confirm the local effects of intravaginal prasterone on moderate to severe dyspareunia, a symptom of vulvovaginal atrophy (VVA) associated with menopause. ...No significant drug-related adverse effect in line with the strictly local action of …
OBJECTIVE: This study aims to confirm the local effects of intravaginal prasterone on moderate to severe dyspareunia, a symptom of vu …
Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R, Reinilä M, Kivinén S. Palatsi R, et al. Acta Derm Venereol. 1986;66(3):225-30. Acta Derm Venereol. 1986. PMID: 2426899 Clinical Trial.
Pituitary function (TRH-LHRH stimulation test) was investigated in male acne patients and serum levels of dehydroepiandrosterone sulphate (DHEA-S), sex hormone binding globulin (SHBG) and other biochemical parameters were investigated in male acne patients and in female ac …
Pituitary function (TRH-LHRH stimulation test) was investigated in male acne patients and serum levels of dehydroepiandrosterone sulp …
1,174 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page